Related Experiment Video

Updated: Aug 17, 2026

Minimal Invasive Resection of Large Retrosternal Thyroid Goiter
04:09

Minimal Invasive Resection of Large Retrosternal Thyroid Goiter

Published on: September 20, 2024

[Low initial dose of levothyroxine for treatment of congenital hypothyroidism]

Zheng-yan Zhao1, Rong-wang Yang, Li Liang

  • 1The Affiliated Children's Hospital, College of Medicine, Zhejiang University, Hangzhou 310003, China. zchzzy@mail.hz.zj.cn

Zhejiang Da Xue Xue Bao. Yi Xue Ban = Journal of Zhejiang University. Medical Sciences
|June 9, 2005
PubMed

Insights

This study found that an initial levothyroxine dose of 4.3 mcg/(kg.d) effectively treats congenital hypothyroidism in infants. Individualizing dosage ensures optimal outcomes for all infants with this condition.

Area of Science:

  • Pediatric Endocrinology
  • Neonatal Screening
  • Thyroid Disorders

Context:

  • Congenital hypothyroidism (CH) requires timely treatment to prevent developmental issues.
  • Neonatal screening identifies newborns with primary CH.
  • Levothyroxine is the standard treatment for CH.

Purpose:

  • To evaluate the efficacy of a low initial dosage of levothyroxine in treating infants with congenital hypothyroidism.
  • To determine the optimal initial levothyroxine dosage based on CH severity.
  • To assess the normalization time of thyroid hormone levels and clinical symptoms.

Summary:

  • 138 infants with CH received initial levothyroxine doses ranging from 3.5 to 4.7 mcg/(kg.d) based on severity.
  • Thyroid hormone levels (TT3, TT4, TSH) normalized within 1-3 months.
  • Clinical symptoms resolved within 2 months, and developmental quotients (DQ) averaged 116.7.

Impact:

  • A mean initial levothyroxine dose of 4.3 mcg/(kg.d) is appropriate for most infants with CH.
  • Individualized dosing is recommended for optimal treatment outcomes.
  • Early and effective treatment of CH supports normal neurodevelopment.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Dosage Regimen: Fixed Dose01:01

Dosage Regimen: Fixed Dose

Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Rational Dosage Regimen: Maintenance Dose and Loading Dose01:24

Rational Dosage Regimen: Maintenance Dose and Loading Dose

A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady state,...
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...